{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:55:31Z","timestamp":1793642131713,"version":"4.5.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shanghai Sailing Program","award":["22YF1440300"],"award-info":[{"award-number":["22YF1440300"]}]},{"name":"\"Jiaotong University Star\" Program for Medical-Engineering Cross-Research of Shanghai Jiao Tong University","award":["YG2022QN015"],"award-info":[{"award-number":["YG2022QN015"]}]},{"name":"Research Project of Disease Treatment and Rational Use of Drugs of the Shandong Pharmaceutical Association","award":["DRM2022007"],"award-info":[{"award-number":["DRM2022007"]}]},{"name":"Shandong Pharmaceutical Association Hospital Rational Drug Use Young and Middle-aged Scientific Research Program","award":["HLYY-2024-01"],"award-info":[{"award-number":["HLYY-2024-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11096-025-01981-5","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T09:53:49Z","timestamp":1755597229000},"page":"1830-1840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical risk assessment of serum creatinine abnormalities during vancomycin therapy: a retrospective study using machine learning models"],"prefix":"10.1007","volume":"47","author":[{"given":"Yilei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"issue":"6","key":"1981_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.amjsurg.2009.08.045","volume":"199","author":"KMF Itani","year":"2010","unstructured":"Itani KMF, Dryden MS, Bhattacharyya H, et al. Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus. Am J Surg. 2010;199(6):804\u201316. https:\/\/doi.org\/10.1016\/j.amjsurg.2009.08.045.","journal-title":"Am J Surg"},{"issue":"9","key":"1981_CR2","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1111\/bcp.15429","volume":"88","author":"JY Kim","year":"2022","unstructured":"Kim JY, Yee J, Yoon HY, et al. Risk factors for vancomycin-associated acute kidney injury: a systematic review and meta-analysis. Br J Clin Pharmacol. 2022;88(9):3977\u201389.","journal-title":"Br J Clin Pharmacol"},{"key":"1981_CR3","doi-asserted-by":"publisher","unstructured":"Oliveira CL, Fernandez-Llimos F, Alves da Costa F et al. A case\/non-case study of a national pharmacovigilance database to explore drug-induced acute kidney injury. Int J Clin Pharm. 2025. https:\/\/doi.org\/10.1007\/s11096-025-01940-0.","DOI":"10.1007\/s11096-025-01940-0"},{"issue":"1","key":"1981_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s11096-024-01822-x","volume":"47","author":"M Swartling","year":"2025","unstructured":"Swartling M, Hamberg A-K, Furebring M, et al. Model-informed precision dosing of vancomycin in clinical practice: an intervention development study. Int J Clin Pharm. 2025;47(1):178\u201386. https:\/\/doi.org\/10.1007\/s11096-024-01822-x.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"1981_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12911-024-02435-0","volume":"24","author":"M Wang","year":"2024","unstructured":"Wang M, Liu G, Ni Z, et al. Acute kidney injury comorbidity analysis based on international classification of diseases-10 codes. BMC Med Inform Decis Mak. 2024;24(1):35. https:\/\/doi.org\/10.1186\/s12911-024-02435-0.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"7","key":"1981_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/phar.1423","volume":"34","author":"CJ Meaney","year":"2014","unstructured":"Meaney CJ, Hynicka LM, Tsoukleris MG. Vancomycin-associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors. Pharmacotherapy. 2014;34(7):653\u201361.","journal-title":"Pharmacotherapy"},{"key":"1981_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2025.149386","volume":"952","author":"N Firouzabadi","year":"2025","unstructured":"Firouzabadi N, Karbasi D, Ghasemiyeh P, et al. Investigation on the association between Osteopontin and Apolipoprotein E gene polymorphisms and vancomycin-induced acute kidney injury: a pharmacokinetic\/pharmacogenetic study in critically ill patients. Gene. 2025;952: 149386.","journal-title":"Gene"},{"key":"1981_CR8","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11764","volume":"9","author":"M Su","year":"2021","unstructured":"Su M, Davis MH, Peterson J, et al. Effect of genetic background on the evolution of Vancomycin-Intermediate Staphylococcus aureus (VISA). PeerJ. 2021;9: e11764. https:\/\/doi.org\/10.7717\/peerj.11764.","journal-title":"PeerJ"},{"key":"1981_CR9","doi-asserted-by":"publisher","unstructured":"Kan W-C, Chen Y-C, Wu V-C et al. Vancomycin-associated acute kidney injury: a narrative review from pathophysiology to clinical application. Int J Mol Sci. 2022;23(4):2052. https:\/\/doi.org\/10.3390\/ijms23042052.","DOI":"10.3390\/ijms23042052"},{"issue":"1","key":"1981_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11096-020-01157-3","volume":"43","author":"J Lines","year":"2021","unstructured":"Lines J, Burchette J, Kullab SM, et al. Evaluation of a trough-only extrapolated area under the curve vancomycin dosing method on clinical outcomes. Int J Clin Pharm. 2021;43(1):263\u20139. https:\/\/doi.org\/10.1007\/s11096-020-01157-3.","journal-title":"Int J Clin Pharm"},{"key":"1981_CR11","doi-asserted-by":"publisher","unstructured":"Din\u00e7el S, Demirpolat E. Evaluation of the appropriateness of vancomycin therapeutic drug monitoring in the intensive care unit with a clinical pharmacy approach, a cross-sectional study. Eur J Hosp Pharm. 2024:ejhpharm-2023\u2013004073. https:\/\/doi.org\/10.1136\/ejhpharm-2023-004073.","DOI":"10.1136\/ejhpharm-2023-004073"},{"issue":"1","key":"1981_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jcph.2363","volume":"64","author":"JJ Yang","year":"2024","unstructured":"Yang JJ, Brett J, Sordo A, et al. The influence of a therapeutic drug monitoring service on vancomycin-associated nephrotoxicity. J Clin Pharmacol. 2024;64(1):19\u201329.","journal-title":"J Clin Pharmacol"},{"key":"1981_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.815188","volume":"13","author":"JY Kim","year":"2022","unstructured":"Kim JY, Kim KY, Yee J, et al. Risk scoring system for vancomycin-associated acute kidney injury. Front Pharmacol. 2022;13: 815188. https:\/\/doi.org\/10.3389\/fphar.2022.815188.","journal-title":"Front Pharmacol"},{"issue":"5","key":"1981_CR14","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1007\/s11096-024-01745-7","volume":"46","author":"M Yin","year":"2024","unstructured":"Yin M, Jiang Y, Yuan Y, et al. Optimizing vancomycin dosing in pediatrics: a machine learning approach to predict trough concentrations in children under four years of age. Int J Clin Pharm. 2024;46(5):1134\u201342. https:\/\/doi.org\/10.1007\/s11096-024-01745-7.","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"1981_CR15","doi-asserted-by":"publisher","first-page":"e00499","DOI":"10.1128\/spectrum.00499-25","volume":"13","author":"K Chen","year":"2025","unstructured":"Chen K, Wang C, Wei Y, et al. Machine learning and population pharmacokinetics: a hybrid approach for optimizing vancomycin therapy in sepsis patients. Microbiol Spectrum. 2025;13(5):e00499-e525. https:\/\/doi.org\/10.1128\/spectrum.00499-25.","journal-title":"Microbiol Spectrum"},{"key":"1981_CR16","doi-asserted-by":"publisher","DOI":"10.2196\/63983","volume":"27","author":"H Lee","year":"2025","unstructured":"Lee H, Kim Y-J, Kim J-H, et al. Optimizing initial vancomycin dosing in hospitalized patients using machine learning approach for enhanced therapeutic outcomes: algorithm development and validation study. J Med Internet Res. 2025;27: e63983. https:\/\/doi.org\/10.2196\/63983.","journal-title":"J Med Internet Res"},{"issue":"11","key":"1981_CR17","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1248\/bpb.b24-00506","volume":"47","author":"S Mizuno","year":"2024","unstructured":"Mizuno S, Noda T, Mogushi K, et al. Prediction of vancomycin-associated nephrotoxicity based on the area under the concentration-time curve of vancomycin: a machine learning analysis. Biol Pharm Bull. 2024;47(11):1946\u201352. https:\/\/doi.org\/10.1248\/bpb.b24-00506.","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"1981_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/cts.12731","volume":"13","author":"C Pan","year":"2020","unstructured":"Pan C, Wen A, Li X, et al. Development and validation of a risk prediction model of vancomycin-associated nephrotoxicity in elderly patients: a pilot study. Clin Transl Sci. 2020;13(3):491\u20137.","journal-title":"Clin Transl Sci"},{"key":"1981_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.924173","volume":"13","author":"R Zhang","year":"2022","unstructured":"Zhang R, Liu Y, Cao J, et al. The incidence and risk factors analysis of acute kidney injury in hospitalized patients received diuretics: a single-center retrospective study. Front Pharmacol. 2022;13: 924173. https:\/\/doi.org\/10.3389\/fphar.2022.924173.","journal-title":"Front Pharmacol"},{"key":"1981_CR20","doi-asserted-by":"publisher","first-page":"1170987","DOI":"10.3389\/fphar.2023.1170987","volume":"14","author":"R Zhang","year":"2023","unstructured":"Zhang R, Gao L, Chen P, et al. Risk-factor analysis and predictive-model development of acute kidney injury in inpatients administered cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium: a single-center retrospective study. Front Pharmacol. 2023;14:1170987. https:\/\/doi.org\/10.3389\/fphar.2023.1170987.","journal-title":"Front Pharmacol"},{"key":"1981_CR21","doi-asserted-by":"publisher","first-page":"1538074","DOI":"10.3389\/fphar.2025.1538074","volume":"16","author":"P Zhang","year":"2025","unstructured":"Zhang P, Chen Q, Lao J, et al. Machine learning modeling for the risk of acute kidney injury in inpatients receiving amikacin and etimicin. Front Pharmacol. 2025;16:1538074. https:\/\/doi.org\/10.3389\/fphar.2025.1538074.","journal-title":"Front Pharmacol"},{"key":"1981_CR22","doi-asserted-by":"publisher","unstructured":"Kellum JA, Lameire N, for the KAKIGWG. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013;17(1):204. https:\/\/doi.org\/10.1186\/cc11454.","DOI":"10.1186\/cc11454"},{"issue":"1","key":"1981_CR23","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3182\/20060329-3-AU-2901.00128","volume":"39","author":"SL Kukreja","year":"2006","unstructured":"Kukreja SL, L\u00f6fberg J, Brenner MJ. A least absolute shrinkage and selection operator (LASSO) for nonlinear system identification. IFAC Proc Volumes. 2006;39(1):814\u20139. https:\/\/doi.org\/10.3182\/20060329-3-AU-2901.00128.","journal-title":"IFAC Proc Volumes"},{"issue":"18","key":"1981_CR24","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1161\/CIRCULATIONAHA.106.682658","volume":"117","author":"MP LaValley","year":"2008","unstructured":"LaValley MP. Logistic regression. Circulation. 2008;117(18):2395\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.682658.","journal-title":"Circulation"},{"issue":"1","key":"1981_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45(1):5\u201332. https:\/\/doi.org\/10.1023\/A:1010933404324.","journal-title":"Mach Learn"},{"issue":"5","key":"1981_CR26","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1214\/aos\/1013203451","volume":"29","author":"JH Friedman","year":"2001","unstructured":"Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Stat. 2001;29(5):1189\u2013232. https:\/\/doi.org\/10.1214\/aos\/1013203451.","journal-title":"Ann Stat"},{"key":"1981_CR27","unstructured":"Ke G, Meng Q, Finley T et al. Lightgbm: a highly efficient gradient boosting decision tree. Adv Neural Inf Process Syst 2017;30."},{"key":"1981_CR28","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost: a scalable tree boosting system. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining; San Francisco, California, USA: Association for Computing Machinery; 2016. p. 785\u201394.","DOI":"10.1145\/2939672.2939785"},{"key":"1981_CR29","doi-asserted-by":"crossref","unstructured":"Hong H, Xiaoling G, Hua Y, editors. Variable selection using mean decrease accuracy and mean decrease gini based on random forest. 2016 7th IEEE International Conference on Software Engineering and Service Science (ICSESS); 2016 26\u201328 2016.","DOI":"10.1109\/ICSESS.2016.7883053"},{"issue":"2","key":"1981_CR30","first-page":"85","volume":"37","author":"K Makris","year":"2016","unstructured":"Makris K, Spanou L. Acute kidney injury: definition, pathophysiology and clinical phenotypes. Clin Biochem Rev. 2016;37(2):85\u201398.","journal-title":"Clin Biochem Rev"},{"issue":"2","key":"1981_CR31","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/ckj\/sfaa142","volume":"14","author":"JP Gaut","year":"2021","unstructured":"Gaut JP, Liapis H. Acute kidney injury pathology and pathophysiology: a retrospective review. Clin Kidney J. 2021;14(2):526\u201336. https:\/\/doi.org\/10.1093\/ckj\/sfaa142.","journal-title":"Clin Kidney J"},{"issue":"1","key":"1981_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-021-00284-z","volume":"7","author":"JA Kellum","year":"2021","unstructured":"Kellum JA, Romagnani P, Ashuntantang G, et al. Acute kidney injury. Nat Rev Dis Primers. 2021;7(1):52. https:\/\/doi.org\/10.1038\/s41572-021-00284-z.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1981_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.semnephrol.2015.01.004","volume":"35","author":"M Heung","year":"2015","unstructured":"Heung M, Koyner JL. Entanglement of sepsis, chronic kidney disease, and other comorbidities in patients who develop acute kidney injury. Semin Nephrol. 2015;35(1):23\u201337. https:\/\/doi.org\/10.1016\/j.semnephrol.2015.01.004.","journal-title":"Semin Nephrol"},{"issue":"6","key":"1981_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00228-019-02648-7","volume":"75","author":"T Hirai","year":"2019","unstructured":"Hirai T, Hanada K, Kanno A, et al. Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment. Eur J Clin Pharmacol. 2019;75(6):859\u201366. https:\/\/doi.org\/10.1007\/s00228-019-02648-7.","journal-title":"Eur J Clin Pharmacol"},{"key":"1981_CR35","doi-asserted-by":"crossref","unstructured":"Gilpin LH, Bau D, Yuan BZ et al., editors. Explaining explanations: an overview of interpretability of machine learning. 2018 IEEE 5th International Conference on Data Science and Advanced Analytics (DSAA); 2018 1\u20133 Oct. 2018.","DOI":"10.1109\/DSAA.2018.00018"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01981-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-01981-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01981-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:08:00Z","timestamp":1763554080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-01981-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1981"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-01981-5","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This retrospective observational study was conducted at the First Affiliated Hospital of Shandong First Medical University and was approved by the institution\u2019s Ethics Committee (Approval No. YXLL-KY-2022-024). Given the retrospective design and the use of anonymized, pre-existing clinical data, the requirement for informed consent was waived by the Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}